These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 32383023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
    Hou Z, Nie C, Si Z, Ma Y.
    Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
    [Abstract] [Full Text] [Related]

  • 3. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
    Jia P, Chen H, Kang H, Qi J, Zhao P, Jiang M, Guo L, Zhou Q, Qian ND, Zhou HB, Xu YJ, Fan Y, Deng LF.
    J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression.
    Wang C, Cai Y, Zhang Y, Xiong Z, Li G, Cui L.
    PLoS One; 2014 Oct; 9(6):e100818. PubMed ID: 24963878
    [Abstract] [Full Text] [Related]

  • 10. Hyperbaric oxygen intervention on expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in spinal cord injury models in rats.
    Zhou Y, Liu XH, Qu SD, Yang J, Wang ZW, Gao CJ, Su QJ.
    Chin Med J (Engl); 2013 Oct; 126(20):3897-903. PubMed ID: 24157153
    [Abstract] [Full Text] [Related]

  • 11. Comparison of deferoxamine and methylprednisolone: protective effect of pharmacological agents on lipid peroxidation in spinal cord injury in rats.
    Dinc C, Iplikcioglu AC, Atabey C, Eroglu A, Topuz K, Ipcioglu O, Demirel D.
    Spine (Phila Pa 1976); 2013 Dec 15; 38(26):E1649-55. PubMed ID: 24108296
    [Abstract] [Full Text] [Related]

  • 12. [Effect of accordion technique and deferoxamine on promoting bone regeneration in distraction osteogenesis].
    Liu K, Shi L, Wang S, Yalikun A, Hamiti Y, Yusufu A.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Aug 15; 38(8):1001-1009. PubMed ID: 39175324
    [Abstract] [Full Text] [Related]

  • 13. HIF-1α and VEGF Are Involved in Deferoxamine-Ameliorated Traumatic Brain Injury.
    Wang K, Jing Y, Xu C, Zhao J, Gong Q, Chen S.
    J Surg Res; 2020 Feb 15; 246():419-426. PubMed ID: 31630885
    [Abstract] [Full Text] [Related]

  • 14. The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads.
    Li J, Fan L, Yu Z, Dang X, Wang K.
    Exp Biol Med (Maywood); 2015 Feb 15; 240(2):273-80. PubMed ID: 25294892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Desferoxamine protects against glucocorticoid-induced osteonecrosis of the femoral head via activating HIF-1α expression.
    Jing X, Du T, Yang X, Zhang W, Wang G, Liu X, Li T, Jiang Z.
    J Cell Physiol; 2020 Dec 15; 235(12):9864-9875. PubMed ID: 32437020
    [Abstract] [Full Text] [Related]

  • 19. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C, Hao LJ, Yang ZH, Chai R, Zhang S, Gu Y, Gao HL, Zhong ML, Wang T, Li JY, Wang ZY.
    Exp Neurol; 2016 Jun 15; 280():13-23. PubMed ID: 26996132
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation.
    Langlois A, Bietiger W, Mandes K, Maillard E, Belcourt A, Pinget M, Kessler L, Sigrist S.
    Transplant Proc; 2008 Mar 15; 40(2):473-6. PubMed ID: 18374106
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.